Filbrandt Wealth Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-15
Closed 188
2021
Q1
$0 Buy
+15
New ﹤0.01% 190